The 10-second takeaway
For the quarter ended Jan. 31 (Q1), Cooper beat expectations on revenues and earnings per share.
Compared to the prior-year quarter, revenue grew and GAAP earnings per share grew significantly.
Margins expanded across the board.
Cooper reported revenue of $326.1 million. The seven analysts polled by S&P Capital IQ foresaw a top line of $319.1 million on the same basis. GAAP reported sales were 11% higher than the prior-year quarter's $293.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.12. The nine earnings estimates compiled by S&P Capital IQ predicted $1.04 per share. GAAP EPS of $1.12 for Q1 were 17% higher than the prior-year quarter's $0.96 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 64.5%, 360 basis points better than the prior-year quarter. Operating margin was 18.9%, 160 basis points better than the prior-year quarter. Net margin was 16.8%, 140 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $349.3 million. On the bottom line, the average EPS estimate is $1.18.
Next year's average estimate for revenue is $1.43 billion. The average EPS estimate is $5.01.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Cooper is outperform, with an average price target of $75.88.
The health-care investing landscape is littered with also-rans and a few major winners. Is Cooper the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company Fool co-founder David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.
- Add Cooper to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Cooper Companies Inc Stock Is Sinking On Disappointing Fourth-Quarter Results
The medical-device maker's stock headed lower today after missing the Street's earnings expectations for the fourth quarter.
5 Reasons to Buy This Health Care Stock -- and Why to Avoid It
A close look at Cooper Companies.
Cooper Leveraging Share Gains for Eye-Opening Growth
Though not cheap, Cooper could be positioning for some significant revenue, margin, and cash flow improvements.